501
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

The role of galactomannan test results in the diagnosis of pediatric invasive aspergillosis

, , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 269-276 | Received 30 Mar 2021, Accepted 15 Nov 2021, Published online: 29 Nov 2021

References

  • Warris A, Lehrnbecher T, Roilides E, et al. ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clin Microbiol Infect. 2019;25(9):1096–1113.
  • Choi SH, Kang ES, Eo H, et al. Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients. Pediatr Blood Cancer. 2013;60(2):316–322.
  • Oz Y, Kiraz N. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods. Expert Rev anti Infect Ther. 2011;9(3):289–298.
  • Pana ZD, Vikelouda K, Roilides E. Diagnosis of invasive fungal diseases in pediatric patients. Expert Rev anti Infect Ther. 2016;14(12):1203–1213.
  • Stergiopoulou T, Meletiadis J, Roilides E, et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol. 2007;127(3):349–355.
  • Red book. Aspergillosis. 2018; Kimberlin D.W., Brady M.T., Jackson M.A., Long S.S. eds. Report of the Committee on Infectious Diseases. 31st ed. 2018;230–234.
  • Pinel C, Fricker-Hidalgo H, Lebeau B, et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the platelia test for diagnosing invasive aspergillosis. J Clin Microbiol. 2003;41(5):2184–2186.
  • Marr KA, Balajee SA, McLaughlin L, et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis. 2004;190(3):641–649.
  • Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006;42(10):1417–1427.
  • Lehrnbecher T, Robinson PD, Fisher BT, et al. Galactomannan, β-D-glucan, and polymerase chain reaction-based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and Meta-analysis. Clin Infect Dis. 2016;63(10):1340–1348.
  • Steinbach WJ, Addison RM, McLaughlin L, et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J. 2007;26(7):558–564.
  • Armenian SH, Nash KA, Kapoor N, et al. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients. J Pediatr Hematol Oncol. 2009;31(12):920–926.
  • Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–1376.
  • Fisher BT, Zaoutis TE, Park JR, et al. Galactomannan antigen testing for diagnosis of invasive aspergillosis in pediatric hematology patients. J Pediatric Infect Dis Soc. 2012;1(2):103–111.
  • Gefen A, Zaidman I, Shachor-Meyouhas Y, et al. Serum galactomannan screening for diagnosis of invasive pulmonary aspergillosis in children after stem cell transplantation or with high-risk leukemia. Pediatr Hematol Oncol. 2015; 32(2):146–152.
  • Badiee P, Alborzi A, Karimi M, et al. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients. J Infect Dev Ctries. 2012;6(4):352–357.
  • Hayden R, Pounds S, Knapp K, et al. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr Infect Dis J. 2008;27(9):815–819.
  • Bialek R, et al. Aspergillus antigen and PCR assays in bone marrow transplanted children. Eur J Med Res . 2002;7.4:177–180.
  • Foy PC, van Burik JA, Weisdorf DJ. Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2007;13(4):440–443.
  • Maertens J, Theunissen K, Verhoef G, et al. False-positive Aspergillus galactomannan antigen test results. Clin Infect Dis. 2004;39(2):289–290.
  • Asano-Mori Y, Kanda Y, Oshima K, et al. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. J Antimicrob Chemother. 2008;61(2):411–416.
  • Dinand V, Anjan M, Oberoi JK, et al. Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children. J Microbiol Immunol Infect. 2016;49(1):66–73.
  • Tong T, Shen J, Xu Y. Serum galactomannan for diagnosing invasive aspergillosis in pediatric patients: a meta-analysis. Microb Pathog. 2018;118:347–356.
  • Singh S, Singh M, Verma N, et al. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis. Med Mycol. 2021;59(2):139–148.
  • Ozen M, Dundar NO. Invasive aspergillosis in children with hematological malignancies. Expert Rev anti Infect Ther. 2011;9(3):299–306.
  • Hovi L, Saxen H, Saarinen ‐Pihkala UM, et al. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatr Blood Cancer. 2007;48(1):28–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.